Distinct qualitative differences between normal and abnormal hemopoietic stem cells in vivo and in vitro

Stem Cells

Volumn 15, Issue 1, 1997, Pages 56-62

  Kawamura, Masayo ^a   Hisha, Hiroko ^a   Li, Yongan ^a   Fukuhara, Shirou ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone marrow transplantation; Hemapoietic stem cells; W BF1 mouse

Indexed keywords

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CELL TRANSPLANTATION; COLONY FORMING UNIT; HEMATOPOIETIC CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; STEM CELL; STROMA CELL;

EID: 0031024035     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150056     Document Type: Article

References (25)

1. Ikehara S, Ohtsuki H, Good RA et al. Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1985;82:7743-7747.
2. Yasumizu R, Sugiura K, Iwai H et al. Treatment of type I diabetes mellitus in non-obese diabetes mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc Natl Acad Sci USA 1987;84:6555-6557.
3. Ikehara S, Good RA, Nakamura T et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985;82:2483-2487.
4. Ikehara S, Yasumizu R, Inaba M et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1989;86:3306-3310.
5. Oyaizu N, Yasumizu R, Miyama-Inaba M et al. (NZW × BXSB)F1 mouse: a new animal model of idiopathic thrombocytopenic purpura. J Exp Med 1988;167:2017-2022.
6. Ikehara S, Inaba M, Ishida S et al. Rationale for transplantation of both allogeneic bone marrow and stromal cells in the treatment of autoimmune diseases. In: Champlin RE, Gale RP, eds. New Strategies in Bone Marrow Transplantation. UCLA Symposia on Molecular and Cellular Biology. New Series, Wiley-Liss, 1991;137:251-257.
7. Ishida T, Inaba M, Hisha H et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation: complete prevention of recurrence of autoimmune diseases in MRL/MP-lpr/lpr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1994;152:3119-3127.
8. 0 phase. Biochem Biophys Res Commun 1987;147:687-694.
9. Ikehara S, Kawamura M, Takao F et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990;87:8341-8344.
10. Miyashima S, Nagata N, Nakagawa T et al. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice. J Immunol 1996;156:79-84.
11. Ogata H, Bradley WG, Inaba M et al. Long-term repopulation of hematolymphoid cells with only a few hemopoietic stem cells in mice. Proc Natl Acad Sci USA 1995;92:5945-5949.
12. Itoh K, Tezuka H, Sakoda H et al. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol 1989;17:145-153.
13. Wamer JF, Dennert G. Effects of a cloned cell line with NK activity on bone marrow transplantations, tumor development and metastasis in vivo. Nature 1982;300:31-34.
14. Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med 1987;166:1499-1509.
15. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985;37:269-290.
16. Motion JI, Siegel BV. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand black mice. Proc Natl Acad Sci USA 1974;71:2162-2165.
17. Akizuki M, Reeves JP, Steinberg AD. Expression of autoimmunity by NZB/NZW marrow. Clin Immunol Immunopathol 1978;10:247-250.
18. Jyonouchi H, Kincade PW, Good RA et al. Reciprocal transfer of abnormalities in clonable B lymphocytes and myeloid progenitors between NZB and DBA/2 mice. J Immunol 1981;127:1232-1235.
19. Nakamura T, Ikehara S, Good RA et al. Abnormal stem cells in autoimmune-prone mice are responsible for premature thymic involution. Thymus 1985;7:151-160.
20. Mizutani H, Engelman RW, Kinjoh K et al. Prevention and induction of occlusive coronary vascular disease in autoimmune (W/B)F1 mice by haploidentical bone marrow transplantation: possible role for anticardiolipin autoantibodies. Blood 1993;82:3091-3097.
21. Marmont AM. Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases? STEM CELLS 1994;12:125-135.
22. Nishimura M, Toki J, Sugiura K et al. Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder. J Exp Med 1994;179:1053-1058.
23. Cherry, Yasumizu R, Toki J et al. Production of hemopoietic stem cell-chemotactic factor by bone marrow stromal cells. Blood 1994;83:964-971.
24. Hashimoto F, Sugiura K, Inoue K et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood (in press).
25. Takao F, Yasumizu R, Soe Than et al. Development of insulin-dependent diabetes mellitus in [(NOD + BALB/c) → NOD] mixed allogeneic bone marrow chimeras. Immunobiol 1995;194:376-389.